Cargando…

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity....

Descripción completa

Detalles Bibliográficos
Autores principales: Gian, Franco Cupido, Matteo, Gelardi, Ignazio, La Mantia, Salvo, Emanuele Aragona, Claudio, Vicini, Giorgio, Ciprandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776168/
https://www.ncbi.nlm.nih.gov/pubmed/31292425
http://dx.doi.org/10.23750/abm.v90i7-S.8656
_version_ 1783456374689103872
author Gian, Franco Cupido
Matteo, Gelardi
Ignazio, La Mantia
Salvo, Emanuele Aragona
Claudio, Vicini
Giorgio, Ciprandi
author_facet Gian, Franco Cupido
Matteo, Gelardi
Ignazio, La Mantia
Salvo, Emanuele Aragona
Claudio, Vicini
Giorgio, Ciprandi
author_sort Gian, Franco Cupido
collection PubMed
description Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity. The current survey, conducted in clinical practice of 84 Italian ORL centers, evaluated its safety and efficacy in the treatment of patients with exacerbated chronic upper airways disease. The 459 (254 males, mean age 44.7 years) patients were evaluated at baseline (T0) and after a 2-week treatment (T1), treated or not-treated with Broncalt®. Signs and symptoms severity were measured by visual analogue scale. Broncalt® significantly, quickly, and safely diminished the clinical features in all sub-groups (p<0.001 for all). In conclusion, Broncalt® is a class II Medical Device able to exert a safe, quick, and effective activity in patients with relapsed chronic ORL disorders. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-6776168
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-67761682019-12-17 Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice Gian, Franco Cupido Matteo, Gelardi Ignazio, La Mantia Salvo, Emanuele Aragona Claudio, Vicini Giorgio, Ciprandi Acta Biomed Original Article Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity. The current survey, conducted in clinical practice of 84 Italian ORL centers, evaluated its safety and efficacy in the treatment of patients with exacerbated chronic upper airways disease. The 459 (254 males, mean age 44.7 years) patients were evaluated at baseline (T0) and after a 2-week treatment (T1), treated or not-treated with Broncalt®. Signs and symptoms severity were measured by visual analogue scale. Broncalt® significantly, quickly, and safely diminished the clinical features in all sub-groups (p<0.001 for all). In conclusion, Broncalt® is a class II Medical Device able to exert a safe, quick, and effective activity in patients with relapsed chronic ORL disorders. (www.actabiomedica.it) Mattioli 1885 2019 2019-12-09 /pmc/articles/PMC6776168/ /pubmed/31292425 http://dx.doi.org/10.23750/abm.v90i7-S.8656 Text en Copyright: © 2019 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Gian, Franco Cupido
Matteo, Gelardi
Ignazio, La Mantia
Salvo, Emanuele Aragona
Claudio, Vicini
Giorgio, Ciprandi
Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title_full Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title_fullStr Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title_full_unstemmed Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title_short Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
title_sort broncalt®, class ii medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776168/
https://www.ncbi.nlm.nih.gov/pubmed/31292425
http://dx.doi.org/10.23750/abm.v90i7-S.8656
work_keys_str_mv AT gianfrancocupido broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice
AT matteogelardi broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice
AT ignaziolamantia broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice
AT salvoemanuelearagona broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice
AT claudiovicini broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice
AT giorgiociprandi broncaltclassiimedicaldeviceinpatientswithchronicrelapsedupperairwaysdiseaseasurveyinclinicalpractice